[Pneumococcal vaccine in adults: comparison of recommendations and discussion of its role].
Pneumococcal infections are a major cause of morbidity and mortality among the elderly and high-risk groups. There is a concern about the expansion of pneumococcal drug resistance. A pneumococcal polysaccharide vaccine exists, which is epidemiologically adapted and has few side effects. The comparison of vaccine recommendations in six countries shows significant divergence. This can be explained by the scanty scientific evidence for the effectiveness of the current vaccine. While awaiting a more effective vaccine, the current vaccine has a limited place in the strategies of preventive medicine.
Borsu
K
K
Département de Médecine Générale, Université de Liège, CHU de Liège, Belgique.
Krammisch
H
H
Franckh
M
M
Giet
D
D
D000328:Adult; D001530:Belgium; D002170:Canada; D005602:France; D005858:Germany; D006801:Humans; D011008:Pneumococcal Infections / Q000382:microbiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage* / Q000276:immunology; D017410:Practice Guidelines as Topic; D013296:Streptococcus pneumoniae / Q000302:isolation & purification; D006113:United Kingdom; D014481:United States
D022242:Pneumococcal Vaccines